Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals directing skin cells to grow too quickly.
Globally North America is the largest market of global psoriasis treatment. Europe is the second largest market for global psoriasis treatment. However the developing market is Asia Pacific that will be the fastest growing region and will be the key to the future.

The global Psoriasis Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Psoriasis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Psoriasis Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Psoriasis Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Psoriasis Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis International AG
Johnson & Johnson
Pfizer Inc.
Merck and Co. Inc.
AbbVie and Amgen
Eli Lilly
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
TNF Inhibitors
Phosphodiesterase Inhibitors
Interleukin Blockers
Others

Segment by Application
Oral
Tropical
Injectable